Literature DB >> 20363604

Inflammatory cytokines as a third signal for T cell activation.

Julie M Curtsinger1, Matthew F Mescher.   

Abstract

CD8 T cells require a third signal, along with Ag and costimulation, to make a productive response and avoid death and/or tolerance induction. Recent studies indicate that IL-12 and Type I IFN (IFNalpha/beta) are the major sources of signal 3 in a variety of responses, and that the two cytokines stimulate a common regulatory program involving altered expression of about 350 genes. Signal 3-driven chromatin remodeling is likely to play a major role in this regulation. Although less well studied, there is emerging evidence that CD4 T cells may also require a 'third signal' for a productive response and that IL-1 can provide this signal. Signal 3 cytokines can replace adjuvants in supporting in vivo T cell responses to peptide and protein antigens, and a better understanding of their activities and mechanisms should contribute to more rational design of vaccines. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20363604      PMCID: PMC2891062          DOI: 10.1016/j.coi.2010.02.013

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  45 in total

1.  Blimp-1 transcription factor is required for the differentiation of effector CD8(+) T cells and memory responses.

Authors:  Axel Kallies; Annie Xin; Gabrielle T Belz; Stephen L Nutt
Journal:  Immunity       Date:  2009-08-06       Impact factor: 31.745

2.  A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection.

Authors:  Haina Shin; Shawn D Blackburn; Andrew M Intlekofer; Charlly Kao; Jill M Angelosanto; Steven L Reiner; E John Wherry
Journal:  Immunity       Date:  2009-08-06       Impact factor: 31.745

3.  Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties.

Authors:  Rachel L Rutishauser; Gislâine A Martins; Sergey Kalachikov; Anmol Chandele; Ian A Parish; Eric Meffre; Joshy Jacob; Kathryn Calame; Susan M Kaech
Journal:  Immunity       Date:  2009-08-06       Impact factor: 31.745

4.  Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory.

Authors:  Pujya Agarwal; Arvind Raghavan; Sarada L Nandiwada; Julie M Curtsinger; Paul R Bohjanen; Daniel L Mueller; Matthew F Mescher
Journal:  J Immunol       Date:  2009-07-10       Impact factor: 5.422

5.  A vital role for interleukin-21 in the control of a chronic viral infection.

Authors:  John S Yi; Ming Du; Allan J Zajac
Journal:  Science       Date:  2009-05-14       Impact factor: 47.728

6.  IFN-alpha enhances peptide vaccine-induced CD8+ T cell numbers, effector function, and antitumor activity.

Authors:  Andrew G Sikora; Nina Jaffarzad; Yared Hailemichael; Alexander Gelbard; Spencer W Stonier; Kimberly S Schluns; Loredana Frasca; Yanyan Lou; Chengwen Liu; Helen A Andersson; Patrick Hwu; Willem W Overwijk
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

7.  IL-21 is required to control chronic viral infection.

Authors:  Heidi Elsaesser; Karsten Sauer; David G Brooks
Journal:  Science       Date:  2009-05-07       Impact factor: 47.728

8.  IL-21R on T cells is critical for sustained functionality and control of chronic viral infection.

Authors:  Anja Fröhlich; Jan Kisielow; Iwana Schmitz; Stefan Freigang; Abdijapar T Shamshiev; Jacqueline Weber; Benjamin J Marsland; Annette Oxenius; Manfred Kopf
Journal:  Science       Date:  2009-05-28       Impact factor: 47.728

9.  Effector T-cell differentiation during viral and bacterial infections: Role of direct IL-12 signals for cell fate decision of CD8(+) T cells.

Authors:  Selina J Keppler; Kerstin Theil; Smiljka Vucikuja; Peter Aichele
Journal:  Eur J Immunol       Date:  2009-07       Impact factor: 5.532

10.  Deviation from a strong Th1-dominated to a modest Th17-dominated CD4 T cell response in the absence of IL-12p40 and type I IFNs sustains protective CD8 T cells.

Authors:  Nural N Orgun; Meredith A Mathis; Christopher B Wilson; Sing Sing Way
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

View more
  228 in total

1.  Dichotomous effects of IFN-γ on dendritic cell function determine the extent of IL-12-driven antitumor T cell immunity.

Authors:  Jamie L Harden; Tao Gu; Mehmet O Kilinc; Rachael B Rowswell-Turner; Lauren P Virtuoso; Nejat K Egilmez
Journal:  J Immunol       Date:  2011-06-01       Impact factor: 5.422

Review 2.  T-cell activation and transplantation tolerance.

Authors:  Bhavana Priyadharshini; Dale L Greiner; Michael A Brehm
Journal:  Transplant Rev (Orlando)       Date:  2011-11-08       Impact factor: 3.943

3.  A quantitative systems approach to identify paracrine mechanisms that locally suppress immune response to Interleukin-12 in the B16 melanoma model.

Authors:  Yogesh M Kulkarni; Emily Chambers; A J Robert McGray; Jason S Ware; Jonathan L Bramson; David J Klinke
Journal:  Integr Biol (Camb)       Date:  2012-07-09       Impact factor: 2.192

Review 4.  Can we prevent type 1 diabetes?

Authors:  Giovanna Beauchamp; Michael J Haller
Journal:  Curr Diab Rep       Date:  2015-11       Impact factor: 4.810

5.  Peripheral Deletion of CD8 T Cells Requires p38 MAPK in Cross-Presenting Dendritic Cells.

Authors:  Trevor Smith; Xiaotian Lin; Marielle Mello; Kristi Marquardt; Jocelyn Cheung; Binfeng Lu; Linda A Sherman; Grégory Verdeil
Journal:  J Immunol       Date:  2017-09-01       Impact factor: 5.422

6.  Elimination of IL-10-inducing T-helper epitopes from an IGFBP-2 vaccine ensures potent antitumor activity.

Authors:  Denise L Cecil; Gregory E Holt; Kyong Hwa Park; Ekram Gad; Lauren Rastetter; Jennifer Childs; Doreen Higgins; Mary L Disis
Journal:  Cancer Res       Date:  2014-04-28       Impact factor: 12.701

7.  Ikaros imposes a barrier to CD8+ T cell differentiation by restricting autocrine IL-2 production.

Authors:  Shaun O'Brien; Rajan M Thomas; Gerald B Wertheim; Fuqin Zhang; Hao Shen; Andrew D Wells
Journal:  J Immunol       Date:  2014-04-28       Impact factor: 5.422

Review 8.  Role of the Immune System in Hypertension.

Authors:  Bernardo Rodriguez-Iturbe; Hector Pons; Richard J Johnson
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

9.  IL-12 Signals through the TCR To Support CD8 Innate Immune Responses.

Authors:  Nicholas P Goplen; Vikas Saxena; Karin M Knudson; Adam G Schrum; Diana Gil; Mark A Daniels; Rose Zamoyska; Emma Teixeiro
Journal:  J Immunol       Date:  2016-08-12       Impact factor: 5.422

10.  Altered CD4+ T cell immunity in nurses occupationally exposed to viral pathogens.

Authors:  G Elias; A Souquette; S Heynderickx; I De Meester; H Jansens; P Beutels; P Van Damme; E Smits; P G Thomas; V Van Tendeloo; B Ogunjimi
Journal:  Clin Exp Immunol       Date:  2018-09-19       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.